nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Vandetanib—RIPK2—leprosy	0.0172	1	CrCbGaD
Bosutinib—Bronchopneumonia—Thalidomide—leprosy	0.0113	0.0904	CcSEcCtD
Bosutinib—Lipase increased—Thalidomide—leprosy	0.00838	0.0672	CcSEcCtD
Bosutinib—CSK—Menadione—Thalidomide—leprosy	0.00752	1	CbGdCrCtD
Bosutinib—Pericarditis—Thalidomide—leprosy	0.0057	0.0456	CcSEcCtD
Bosutinib—Febrile neutropenia—Thalidomide—leprosy	0.00409	0.0328	CcSEcCtD
Bosutinib—Pleural effusion—Thalidomide—leprosy	0.00322	0.0258	CcSEcCtD
Bosutinib—Nasopharyngitis—Dapsone—leprosy	0.00312	0.025	CcSEcCtD
Bosutinib—Influenza—Dapsone—leprosy	0.00302	0.0242	CcSEcCtD
Bosutinib—Acne—Thalidomide—leprosy	0.00293	0.0235	CcSEcCtD
Bosutinib—Hyperkalaemia—Thalidomide—leprosy	0.00242	0.0194	CcSEcCtD
Bosutinib—Tinnitus—Dapsone—leprosy	0.00225	0.0181	CcSEcCtD
Bosutinib—Rash maculo-papular—Thalidomide—leprosy	0.00224	0.0179	CcSEcCtD
Bosutinib—Renal failure acute—Thalidomide—leprosy	0.00194	0.0155	CcSEcCtD
Bosutinib—Cough—Dapsone—leprosy	0.00184	0.0147	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00179	0.0143	CcSEcCtD
Bosutinib—Face oedema—Thalidomide—leprosy	0.00173	0.0138	CcSEcCtD
Bosutinib—TLK1—testis—leprosy	0.00168	0.00435	CbGeAlD
Bosutinib—CLK1—eye—leprosy	0.00168	0.00434	CbGeAlD
Bosutinib—Blood creatinine increased—Thalidomide—leprosy	0.00168	0.0134	CcSEcCtD
Bosutinib—Dehydration—Thalidomide—leprosy	0.00166	0.0133	CcSEcCtD
Bosutinib—PRKCQ—testis—leprosy	0.00165	0.00428	CbGeAlD
Bosutinib—TLK1—nervous system—leprosy	0.00165	0.00426	CbGeAlD
Bosutinib—CAMK2G—eye—leprosy	0.00165	0.00426	CbGeAlD
Bosutinib—CHEK2—tendon—leprosy	0.00163	0.00423	CbGeAlD
Bosutinib—STK33—testis—leprosy	0.00163	0.00423	CbGeAlD
Bosutinib—PRKCQ—nervous system—leprosy	0.00162	0.00421	CbGeAlD
Bosutinib—DMPK—tendon—leprosy	0.00162	0.0042	CbGeAlD
Bosutinib—WEE1—tendon—leprosy	0.00162	0.0042	CbGeAlD
Bosutinib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00161	0.0129	CcSEcCtD
Bosutinib—SIK2—nervous system—leprosy	0.0016	0.00415	CbGeAlD
Bosutinib—BMPR2—skin of body—leprosy	0.0016	0.00414	CbGeAlD
Bosutinib—FRK—testis—leprosy	0.00159	0.00412	CbGeAlD
Bosutinib—PKMYT1—testis—leprosy	0.00159	0.00412	CbGeAlD
Bosutinib—Alanine aminotransferase increased—Thalidomide—leprosy	0.00158	0.0126	CcSEcCtD
Bosutinib—PKMYT1—nervous system—leprosy	0.00156	0.00404	CbGeAlD
Bosutinib—CLK3—testis—leprosy	0.00155	0.00402	CbGeAlD
Bosutinib—DSTYK—testis—leprosy	0.00155	0.00402	CbGeAlD
Bosutinib—STK25—tendon—leprosy	0.00155	0.00401	CbGeAlD
Bosutinib—Influenza—Thalidomide—leprosy	0.00155	0.0124	CcSEcCtD
Bosutinib—HIPK4—testis—leprosy	0.00153	0.00397	CbGeAlD
Bosutinib—CLK3—nervous system—leprosy	0.00152	0.00395	CbGeAlD
Bosutinib—CASK—testis—leprosy	0.00152	0.00393	CbGeAlD
Bosutinib—PHKG1—testis—leprosy	0.00152	0.00393	CbGeAlD
Bosutinib—ULK3—eye—leprosy	0.00151	0.0039	CbGeAlD
Bosutinib—PLK2—tendon—leprosy	0.0015	0.00389	CbGeAlD
Bosutinib—EIF2AK1—testis—leprosy	0.0015	0.00389	CbGeAlD
Bosutinib—SIK3—tendon—leprosy	0.00149	0.00387	CbGeAlD
Bosutinib—EPHB2—nervous system—leprosy	0.00149	0.00386	CbGeAlD
Bosutinib—PHKG1—nervous system—leprosy	0.00149	0.00386	CbGeAlD
Bosutinib—MAP2K1—skin of body—leprosy	0.00149	0.00385	CbGeAlD
Bosutinib—STK35—skin of body—leprosy	0.00149	0.00385	CbGeAlD
Bosutinib—Bronchitis—Thalidomide—leprosy	0.00149	0.0119	CcSEcCtD
Bosutinib—CSK—skin of body—leprosy	0.00148	0.00383	CbGeAlD
Bosutinib—TXK—testis—leprosy	0.00147	0.00381	CbGeAlD
Bosutinib—CSNK1A1—skin of body—leprosy	0.00147	0.0038	CbGeAlD
Bosutinib—Pancytopenia—Thalidomide—leprosy	0.00147	0.0118	CcSEcCtD
Bosutinib—TBK1—eye—leprosy	0.00146	0.00379	CbGeAlD
Bosutinib—SRMS—nervous system—leprosy	0.00146	0.00377	CbGeAlD
Bosutinib—EPHA8—testis—leprosy	0.00146	0.00377	CbGeAlD
Bosutinib—FES—testis—leprosy	0.00146	0.00377	CbGeAlD
Bosutinib—VRK2—testis—leprosy	0.00146	0.00377	CbGeAlD
Bosutinib—Neutropenia—Thalidomide—leprosy	0.00145	0.0116	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Thalidomide—leprosy	0.00144	0.0115	CcSEcCtD
Bosutinib—EPHA8—nervous system—leprosy	0.00143	0.0037	CbGeAlD
Bosutinib—SYK—testis—leprosy	0.00143	0.00369	CbGeAlD
Bosutinib—TNIK—testis—leprosy	0.00143	0.00369	CbGeAlD
Bosutinib—CAMK1D—tendon—leprosy	0.00142	0.00368	CbGeAlD
Bosutinib—CDK2—testis—leprosy	0.00141	0.00366	CbGeAlD
Bosutinib—RPS6KB1—eye—leprosy	0.00141	0.00365	CbGeAlD
Bosutinib—STK24—tendon—leprosy	0.0014	0.00364	CbGeAlD
Bosutinib—Gastrointestinal pain—Dapsone—leprosy	0.0014	0.0112	CcSEcCtD
Bosutinib—STK26—testis—leprosy	0.0014	0.00363	CbGeAlD
Bosutinib—AXL—eye—leprosy	0.00139	0.00361	CbGeAlD
Bosutinib—CDK2—nervous system—leprosy	0.00139	0.00359	CbGeAlD
Bosutinib—Pneumonia—Thalidomide—leprosy	0.00139	0.0111	CcSEcCtD
Bosutinib—Infestation NOS—Thalidomide—leprosy	0.00138	0.011	CcSEcCtD
Bosutinib—Infestation—Thalidomide—leprosy	0.00138	0.011	CcSEcCtD
Bosutinib—STK26—nervous system—leprosy	0.00137	0.00356	CbGeAlD
Bosutinib—CSNK1E—skin of body—leprosy	0.00136	0.00352	CbGeAlD
Bosutinib—FER—tendon—leprosy	0.00136	0.00352	CbGeAlD
Bosutinib—Body temperature increased—Dapsone—leprosy	0.00136	0.0109	CcSEcCtD
Bosutinib—Abdominal pain—Dapsone—leprosy	0.00136	0.0109	CcSEcCtD
Bosutinib—Renal failure—Thalidomide—leprosy	0.00135	0.0109	CcSEcCtD
Bosutinib—CHEK2—testis—leprosy	0.00135	0.0035	CbGeAlD
Bosutinib—WEE1—testis—leprosy	0.00134	0.00347	CbGeAlD
Bosutinib—DMPK—testis—leprosy	0.00134	0.00347	CbGeAlD
Bosutinib—SIK1—skin of body—leprosy	0.00134	0.00347	CbGeAlD
Bosutinib—MAP4K1—tendon—leprosy	0.00133	0.00345	CbGeAlD
Bosutinib—BTK—tendon—leprosy	0.00133	0.00343	CbGeAlD
Bosutinib—DMPK—nervous system—leprosy	0.00132	0.00341	CbGeAlD
Bosutinib—WEE1—nervous system—leprosy	0.00132	0.00341	CbGeAlD
Bosutinib—ERBB3—skin of body—leprosy	0.00131	0.0034	CbGeAlD
Bosutinib—MAP2K2—skin of body—leprosy	0.00131	0.00339	CbGeAlD
Bosutinib—MAP4K2—tendon—leprosy	0.00129	0.00333	CbGeAlD
Bosutinib—Agranulocytosis—Thalidomide—leprosy	0.00129	0.0103	CcSEcCtD
Bosutinib—STK25—testis—leprosy	0.00128	0.00332	CbGeAlD
Bosutinib—PTK2—skin of body—leprosy	0.00127	0.0033	CbGeAlD
Bosutinib—EPHA3—testis—leprosy	0.00127	0.00329	CbGeAlD
Bosutinib—STK3—tendon—leprosy	0.00127	0.00329	CbGeAlD
Bosutinib—ERBB4—tendon—leprosy	0.00127	0.00329	CbGeAlD
Bosutinib—STK25—nervous system—leprosy	0.00126	0.00326	CbGeAlD
Bosutinib—EPHA3—nervous system—leprosy	0.00125	0.00323	CbGeAlD
Bosutinib—PLK2—testis—leprosy	0.00125	0.00323	CbGeAlD
Bosutinib—SIK3—testis—leprosy	0.00124	0.0032	CbGeAlD
Bosutinib—Hepatitis—Thalidomide—leprosy	0.00124	0.00991	CcSEcCtD
Bosutinib—PLK2—nervous system—leprosy	0.00122	0.00317	CbGeAlD
Bosutinib—Urinary tract disorder—Thalidomide—leprosy	0.00122	0.00979	CcSEcCtD
Bosutinib—Oedema peripheral—Thalidomide—leprosy	0.00122	0.00977	CcSEcCtD
Bosutinib—BMPR2—tendon—leprosy	0.00122	0.00315	CbGeAlD
Bosutinib—SIK3—nervous system—leprosy	0.00121	0.00314	CbGeAlD
Bosutinib—AXL—skin of body—leprosy	0.00121	0.00314	CbGeAlD
Bosutinib—Urethral disorder—Thalidomide—leprosy	0.00121	0.00972	CcSEcCtD
Bosutinib—STK36—tendon—leprosy	0.00121	0.00313	CbGeAlD
Bosutinib—MERTK—tendon—leprosy	0.00119	0.00309	CbGeAlD
Bosutinib—STK4—testis—leprosy	0.00119	0.00308	CbGeAlD
Bosutinib—YES1—eye—leprosy	0.00118	0.00305	CbGeAlD
Bosutinib—CAMK1D—testis—leprosy	0.00118	0.00305	CbGeAlD
Bosutinib—MAP4K4—tendon—leprosy	0.00117	0.00304	CbGeAlD
Bosutinib—Erythema multiforme—Thalidomide—leprosy	0.00117	0.00937	CcSEcCtD
Bosutinib—STK4—nervous system—leprosy	0.00117	0.00303	CbGeAlD
Bosutinib—BCR—tendon—leprosy	0.00116	0.00301	CbGeAlD
Bosutinib—STK24—testis—leprosy	0.00116	0.00301	CbGeAlD
Bosutinib—TAOK3—eye—leprosy	0.00116	0.00301	CbGeAlD
Bosutinib—MAP3K12—tendon—leprosy	0.00116	0.00299	CbGeAlD
Bosutinib—CAMK1D—nervous system—leprosy	0.00116	0.00299	CbGeAlD
Bosutinib—Tinnitus—Thalidomide—leprosy	0.00115	0.00924	CcSEcCtD
Bosutinib—Cardiac disorder—Thalidomide—leprosy	0.00115	0.0092	CcSEcCtD
Bosutinib—STK24—nervous system—leprosy	0.00114	0.00296	CbGeAlD
Bosutinib—FYN—skin of body—leprosy	0.00114	0.00294	CbGeAlD
Bosutinib—SRC—eye—leprosy	0.00113	0.00293	CbGeAlD
Bosutinib—STK35—tendon—leprosy	0.00113	0.00293	CbGeAlD
Bosutinib—TYRO3—testis—leprosy	0.00113	0.00291	CbGeAlD
Bosutinib—ALK—testis—leprosy	0.00113	0.00291	CbGeAlD
Bosutinib—FER—testis—leprosy	0.00113	0.00291	CbGeAlD
Bosutinib—CSK—tendon—leprosy	0.00112	0.00291	CbGeAlD
Bosutinib—CSNK1A1—tendon—leprosy	0.00112	0.00289	CbGeAlD
Bosutinib—Immune system disorder—Thalidomide—leprosy	0.00112	0.00895	CcSEcCtD
Bosutinib—Mediastinal disorder—Thalidomide—leprosy	0.00111	0.00893	CcSEcCtD
Bosutinib—HCK—tendon—leprosy	0.00111	0.00288	CbGeAlD
Bosutinib—CLK1—tendon—leprosy	0.00111	0.00288	CbGeAlD
Bosutinib—MAP3K3—skin of body—leprosy	0.00111	0.00287	CbGeAlD
Bosutinib—FER—nervous system—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—EPHA5—nervous system—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—ALK—nervous system—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—TYRO3—nervous system—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—ABL2—tendon—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—MAP4K1—testis—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—MAP3K19—testis—leprosy	0.0011	0.00286	CbGeAlD
Bosutinib—LYN—nervous system—leprosy	0.0011	0.00285	CbGeAlD
Bosutinib—BTK—testis—leprosy	0.0011	0.00284	CbGeAlD
Bosutinib—Vomiting—Dapsone—leprosy	0.00109	0.00875	CcSEcCtD
Bosutinib—CAMK2G—tendon—leprosy	0.00109	0.00282	CbGeAlD
Bosutinib—BMP2K—tendon—leprosy	0.00109	0.00282	CbGeAlD
Bosutinib—MAP3K19—nervous system—leprosy	0.00108	0.0028	CbGeAlD
Bosutinib—TNK2—testis—leprosy	0.00108	0.0028	CbGeAlD
Bosutinib—LRRK2—tendon—leprosy	0.00108	0.0028	CbGeAlD
Bosutinib—Malnutrition—Thalidomide—leprosy	0.00108	0.00863	CcSEcCtD
Bosutinib—Headache—Dapsone—leprosy	0.00108	0.00862	CcSEcCtD
Bosutinib—MAP4K2—testis—leprosy	0.00107	0.00276	CbGeAlD
Bosutinib—TNK2—nervous system—leprosy	0.00106	0.00275	CbGeAlD
Bosutinib—Dysgeusia—Thalidomide—leprosy	0.00105	0.00845	CcSEcCtD
Bosutinib—PTK2B—tendon—leprosy	0.00105	0.00273	CbGeAlD
Bosutinib—ERBB4—testis—leprosy	0.00105	0.00272	CbGeAlD
Bosutinib—STK3—testis—leprosy	0.00105	0.00272	CbGeAlD
Bosutinib—Back pain—Thalidomide—leprosy	0.00104	0.00835	CcSEcCtD
Bosutinib—ROCK1—testis—leprosy	0.00104	0.00269	CbGeAlD
Bosutinib—CSNK1E—tendon—leprosy	0.00104	0.00268	CbGeAlD
Bosutinib—ERBB4—nervous system—leprosy	0.00103	0.00267	CbGeAlD
Bosutinib—Nausea—Dapsone—leprosy	0.00102	0.00817	CcSEcCtD
Bosutinib—SIK1—tendon—leprosy	0.00102	0.00264	CbGeAlD
Bosutinib—IRAK4—tendon—leprosy	0.00102	0.00264	CbGeAlD
Bosutinib—ROCK1—nervous system—leprosy	0.00102	0.00264	CbGeAlD
Bosutinib—CSF1R—eye—leprosy	0.00102	0.00263	CbGeAlD
Bosutinib—EPHA4—tendon—leprosy	0.00101	0.00261	CbGeAlD
Bosutinib—BMPR2—testis—leprosy	0.00101	0.00261	CbGeAlD
Bosutinib—EPHB3—testis—leprosy	0.001	0.00259	CbGeAlD
Bosutinib—STK36—testis—leprosy	0.001	0.00259	CbGeAlD
Bosutinib—Ill-defined disorder—Thalidomide—leprosy	0.000999	0.00801	CcSEcCtD
Bosutinib—ULK3—tendon—leprosy	0.000997	0.00258	CbGeAlD
Bosutinib—MAP2K2—tendon—leprosy	0.000997	0.00258	CbGeAlD
Bosutinib—Anaemia—Thalidomide—leprosy	0.000995	0.00798	CcSEcCtD
Bosutinib—BMPR2—nervous system—leprosy	0.00099	0.00256	CbGeAlD
Bosutinib—MERTK—testis—leprosy	0.000989	0.00256	CbGeAlD
Bosutinib—SRC—skin of body—leprosy	0.000985	0.00255	CbGeAlD
Bosutinib—EPHB3—nervous system—leprosy	0.000982	0.00254	CbGeAlD
Bosutinib—STK36—nervous system—leprosy	0.000982	0.00254	CbGeAlD
Bosutinib—MAP3K7—tendon—leprosy	0.000981	0.00254	CbGeAlD
Bosutinib—Malaise—Thalidomide—leprosy	0.000971	0.00778	CcSEcCtD
Bosutinib—MAP4K4—testis—leprosy	0.000971	0.00251	CbGeAlD
Bosutinib—MERTK—nervous system—leprosy	0.000971	0.00251	CbGeAlD
Bosutinib—PTK2—tendon—leprosy	0.000969	0.00251	CbGeAlD
Bosutinib—TBK1—tendon—leprosy	0.000969	0.00251	CbGeAlD
Bosutinib—BCR—testis—leprosy	0.000964	0.0025	CbGeAlD
Bosutinib—NUAK2—testis—leprosy	0.000964	0.0025	CbGeAlD
Bosutinib—Leukopenia—Thalidomide—leprosy	0.000964	0.00772	CcSEcCtD
Bosutinib—MAP3K12—testis—leprosy	0.000957	0.00248	CbGeAlD
Bosutinib—MAP4K4—nervous system—leprosy	0.000953	0.00247	CbGeAlD
Bosutinib—IRAK1—tendon—leprosy	0.00095	0.00246	CbGeAlD
Bosutinib—BCR—nervous system—leprosy	0.000946	0.00245	CbGeAlD
Bosutinib—Cough—Thalidomide—leprosy	0.00094	0.00753	CcSEcCtD
Bosutinib—MAP3K12—nervous system—leprosy	0.000939	0.00243	CbGeAlD
Bosutinib—MAP2K1—testis—leprosy	0.000938	0.00243	CbGeAlD
Bosutinib—STK35—testis—leprosy	0.000938	0.00243	CbGeAlD
Bosutinib—RPS6KB1—tendon—leprosy	0.000933	0.00241	CbGeAlD
Bosutinib—CSK—testis—leprosy	0.000932	0.00241	CbGeAlD
Bosutinib—FGR—tendon—leprosy	0.000927	0.0024	CbGeAlD
Bosutinib—CSNK1A1—testis—leprosy	0.000925	0.0024	CbGeAlD
Bosutinib—AXL—tendon—leprosy	0.000923	0.00239	CbGeAlD
Bosutinib—MAP2K1—nervous system—leprosy	0.00092	0.00238	CbGeAlD
Bosutinib—STK35—nervous system—leprosy	0.00092	0.00238	CbGeAlD
Bosutinib—HCK—testis—leprosy	0.00092	0.00238	CbGeAlD
Bosutinib—CLK1—testis—leprosy	0.00092	0.00238	CbGeAlD
Bosutinib—Myalgia—Thalidomide—leprosy	0.000917	0.00735	CcSEcCtD
Bosutinib—Chest pain—Thalidomide—leprosy	0.000917	0.00735	CcSEcCtD
Bosutinib—Arthralgia—Thalidomide—leprosy	0.000917	0.00735	CcSEcCtD
Bosutinib—CSK—nervous system—leprosy	0.000914	0.00237	CbGeAlD
Bosutinib—ABL2—testis—leprosy	0.000914	0.00237	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00091	0.0073	CcSEcCtD
Bosutinib—CSNK1A1—nervous system—leprosy	0.000908	0.00235	CbGeAlD
Bosutinib—Discomfort—Thalidomide—leprosy	0.000906	0.00726	CcSEcCtD
Bosutinib—CAMK2G—testis—leprosy	0.000903	0.00234	CbGeAlD
Bosutinib—BMP2K—testis—leprosy	0.000903	0.00234	CbGeAlD
Bosutinib—HCK—nervous system—leprosy	0.000903	0.00234	CbGeAlD
Bosutinib—CLK1—nervous system—leprosy	0.000903	0.00234	CbGeAlD
Bosutinib—PDGFRB—eye—leprosy	0.000902	0.00233	CbGeAlD
Bosutinib—LRRK2—testis—leprosy	0.000895	0.00232	CbGeAlD
Bosutinib—EGFR—testis—leprosy	0.000892	0.00231	CbGeAlD
Bosutinib—SLK—tendon—leprosy	0.000889	0.0023	CbGeAlD
Bosutinib—CAMK2G—nervous system—leprosy	0.000886	0.00229	CbGeAlD
Bosutinib—BMP2K—nervous system—leprosy	0.000886	0.00229	CbGeAlD
Bosutinib—CSF1R—skin of body—leprosy	0.000885	0.00229	CbGeAlD
Bosutinib—EPHB4—tendon—leprosy	0.000882	0.00228	CbGeAlD
Bosutinib—Oedema—Thalidomide—leprosy	0.000879	0.00704	CcSEcCtD
Bosutinib—LRRK2—nervous system—leprosy	0.000878	0.00227	CbGeAlD
Bosutinib—Infection—Thalidomide—leprosy	0.000873	0.007	CcSEcCtD
Bosutinib—PTK2B—testis—leprosy	0.000872	0.00226	CbGeAlD
Bosutinib—EPHA2—tendon—leprosy	0.000865	0.00224	CbGeAlD
Bosutinib—FYN—tendon—leprosy	0.000864	0.00224	CbGeAlD
Bosutinib—Nervous system disorder—Thalidomide—leprosy	0.000862	0.00691	CcSEcCtD
Bosutinib—Thrombocytopenia—Thalidomide—leprosy	0.00086	0.0069	CcSEcCtD
Bosutinib—CSNK1E—testis—leprosy	0.000858	0.00222	CbGeAlD
Bosutinib—PTK2B—nervous system—leprosy	0.000856	0.00222	CbGeAlD
Bosutinib—Skin disorder—Thalidomide—leprosy	0.000854	0.00684	CcSEcCtD
Bosutinib—MAP4K5—tendon—leprosy	0.000844	0.00219	CbGeAlD
Bosutinib—MAP3K3—tendon—leprosy	0.000844	0.00219	CbGeAlD
Bosutinib—SIK1—testis—leprosy	0.000844	0.00219	CbGeAlD
Bosutinib—IRAK4—testis—leprosy	0.000844	0.00219	CbGeAlD
Bosutinib—CSNK1E—nervous system—leprosy	0.000842	0.00218	CbGeAlD
Bosutinib—EPHA4—testis—leprosy	0.000836	0.00216	CbGeAlD
Bosutinib—SIK1—nervous system—leprosy	0.000829	0.00215	CbGeAlD
Bosutinib—IRAK4—nervous system—leprosy	0.000829	0.00215	CbGeAlD
Bosutinib—ERBB3—testis—leprosy	0.000828	0.00214	CbGeAlD
Bosutinib—MAP2K2—testis—leprosy	0.000826	0.00214	CbGeAlD
Bosutinib—ULK3—testis—leprosy	0.000826	0.00214	CbGeAlD
Bosutinib—EPHA4—nervous system—leprosy	0.00082	0.00212	CbGeAlD
Bosutinib—MAP3K2—testis—leprosy	0.00082	0.00212	CbGeAlD
Bosutinib—ERBB3—nervous system—leprosy	0.000812	0.0021	CbGeAlD
Bosutinib—MAP3K7—testis—leprosy	0.000812	0.0021	CbGeAlD
Bosutinib—MAP2K2—nervous system—leprosy	0.00081	0.0021	CbGeAlD
Bosutinib—ULK3—nervous system—leprosy	0.00081	0.0021	CbGeAlD
Bosutinib—MAP3K2—nervous system—leprosy	0.000804	0.00208	CbGeAlD
Bosutinib—ABL1—eye—leprosy	0.000804	0.00208	CbGeAlD
Bosutinib—TBK1—testis—leprosy	0.000803	0.00208	CbGeAlD
Bosutinib—PTK2—testis—leprosy	0.000803	0.00208	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000801	0.00642	CcSEcCtD
Bosutinib—TBK1—nervous system—leprosy	0.000788	0.00204	CbGeAlD
Bosutinib—PTK2—nervous system—leprosy	0.000788	0.00204	CbGeAlD
Bosutinib—IRAK1—testis—leprosy	0.000787	0.00204	CbGeAlD
Bosutinib—PDGFRB—skin of body—leprosy	0.000785	0.00203	CbGeAlD
Bosutinib—Dyspnoea—Thalidomide—leprosy	0.000784	0.00628	CcSEcCtD
Bosutinib—YES1—tendon—leprosy	0.00078	0.00202	CbGeAlD
Bosutinib—STK10—tendon—leprosy	0.000773	0.002	CbGeAlD
Bosutinib—RPS6KB1—testis—leprosy	0.000772	0.002	CbGeAlD
Bosutinib—TAOK3—tendon—leprosy	0.00077	0.00199	CbGeAlD
Bosutinib—FGR—testis—leprosy	0.000767	0.00199	CbGeAlD
Bosutinib—LCK—testis—leprosy	0.000767	0.00199	CbGeAlD
Bosutinib—AXL—testis—leprosy	0.000764	0.00198	CbGeAlD
Bosutinib—Decreased appetite—Thalidomide—leprosy	0.000764	0.00612	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Thalidomide—leprosy	0.000759	0.00608	CcSEcCtD
Bosutinib—RPS6KB1—nervous system—leprosy	0.000758	0.00196	CbGeAlD
Bosutinib—Fatigue—Thalidomide—leprosy	0.000758	0.00607	CcSEcCtD
Bosutinib—FGR—nervous system—leprosy	0.000753	0.00195	CbGeAlD
Bosutinib—Pain—Thalidomide—leprosy	0.000752	0.00602	CcSEcCtD
Bosutinib—AXL—nervous system—leprosy	0.00075	0.00194	CbGeAlD
Bosutinib—SLK—testis—leprosy	0.000736	0.00191	CbGeAlD
Bosutinib—EPHB4—testis—leprosy	0.000731	0.00189	CbGeAlD
Bosutinib—Feeling abnormal—Thalidomide—leprosy	0.000724	0.0058	CcSEcCtD
Bosutinib—Gastrointestinal pain—Thalidomide—leprosy	0.000719	0.00576	CcSEcCtD
Bosutinib—EPHA2—testis—leprosy	0.000717	0.00186	CbGeAlD
Bosutinib—FYN—testis—leprosy	0.000715	0.00185	CbGeAlD
Bosutinib—EPHA2—nervous system—leprosy	0.000703	0.00182	CbGeAlD
Bosutinib—FYN—nervous system—leprosy	0.000702	0.00182	CbGeAlD
Bosutinib—ABL1—skin of body—leprosy	0.000699	0.00181	CbGeAlD
Bosutinib—MAP4K5—testis—leprosy	0.000699	0.00181	CbGeAlD
Bosutinib—MAP3K3—testis—leprosy	0.000699	0.00181	CbGeAlD
Bosutinib—Urticaria—Thalidomide—leprosy	0.000698	0.00559	CcSEcCtD
Bosutinib—Abdominal pain—Thalidomide—leprosy	0.000695	0.00557	CcSEcCtD
Bosutinib—Body temperature increased—Thalidomide—leprosy	0.000695	0.00557	CcSEcCtD
Bosutinib—MAP2K5—tendon—leprosy	0.00069	0.00179	CbGeAlD
Bosutinib—MAP3K3—nervous system—leprosy	0.000686	0.00178	CbGeAlD
Bosutinib—MAP4K5—nervous system—leprosy	0.000686	0.00178	CbGeAlD
Bosutinib—CSF1R—tendon—leprosy	0.000673	0.00174	CbGeAlD
Bosutinib—YES1—testis—leprosy	0.000646	0.00167	CbGeAlD
Bosutinib—STK10—testis—leprosy	0.00064	0.00166	CbGeAlD
Bosutinib—TAOK3—testis—leprosy	0.000637	0.00165	CbGeAlD
Bosutinib—YES1—nervous system—leprosy	0.000634	0.00164	CbGeAlD
Bosutinib—Asthenia—Thalidomide—leprosy	0.000631	0.00505	CcSEcCtD
Bosutinib—STK10—nervous system—leprosy	0.000628	0.00163	CbGeAlD
Bosutinib—TAOK3—nervous system—leprosy	0.000626	0.00162	CbGeAlD
Bosutinib—Pruritus—Thalidomide—leprosy	0.000622	0.00498	CcSEcCtD
Bosutinib—SRC—testis—leprosy	0.000621	0.00161	CbGeAlD
Bosutinib—SRC—nervous system—leprosy	0.00061	0.00158	CbGeAlD
Bosutinib—Diarrhoea—Thalidomide—leprosy	0.000601	0.00482	CcSEcCtD
Bosutinib—PDGFRB—tendon—leprosy	0.000597	0.00155	CbGeAlD
Bosutinib—Dizziness—Thalidomide—leprosy	0.000581	0.00466	CcSEcCtD
Bosutinib—MAP2K5—testis—leprosy	0.000571	0.00148	CbGeAlD
Bosutinib—MAP2K5—nervous system—leprosy	0.000561	0.00145	CbGeAlD
Bosutinib—Vomiting—Thalidomide—leprosy	0.000559	0.00448	CcSEcCtD
Bosutinib—CSF1R—testis—leprosy	0.000558	0.00144	CbGeAlD
Bosutinib—Rash—Thalidomide—leprosy	0.000554	0.00444	CcSEcCtD
Bosutinib—Dermatitis—Thalidomide—leprosy	0.000554	0.00444	CcSEcCtD
Bosutinib—Headache—Thalidomide—leprosy	0.000551	0.00441	CcSEcCtD
Bosutinib—CSF1R—nervous system—leprosy	0.000547	0.00142	CbGeAlD
Bosutinib—ABL1—tendon—leprosy	0.000532	0.00138	CbGeAlD
Bosutinib—Nausea—Thalidomide—leprosy	0.000522	0.00418	CcSEcCtD
Bosutinib—PDGFRB—testis—leprosy	0.000495	0.00128	CbGeAlD
Bosutinib—PDGFRB—nervous system—leprosy	0.000485	0.00126	CbGeAlD
Bosutinib—ABCB1—blood vessel—leprosy	0.00047	0.00122	CbGeAlD
Bosutinib—ABL1—testis—leprosy	0.000441	0.00114	CbGeAlD
Bosutinib—ABL1—nervous system—leprosy	0.000433	0.00112	CbGeAlD
Bosutinib—CYP3A4—nervous system—leprosy	0.00019	0.000492	CbGeAlD
Bosutinib—ABCB1—testis—leprosy	0.000137	0.000355	CbGeAlD
Bosutinib—ABCB1—nervous system—leprosy	0.000135	0.000348	CbGeAlD
Bosutinib—YES1—Hemostasis—IL2—leprosy	5.17e-05	0.000111	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD8A—leprosy	5.17e-05	0.000111	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—RIPK2—leprosy	5.15e-05	0.000111	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—TLR2—leprosy	5.15e-05	0.000111	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—HLA-DRB1—leprosy	5.13e-05	0.000111	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD8A—leprosy	5.13e-05	0.00011	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—CD4—leprosy	5.13e-05	0.00011	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—IL2—leprosy	5.13e-05	0.00011	CbGpPWpGaD
Bosutinib—SYK—Immune System—IL2—leprosy	5.11e-05	0.00011	CbGpPWpGaD
Bosutinib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	5.07e-05	0.000109	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—CD4—leprosy	5.06e-05	0.000109	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—HLA-DRB1—leprosy	5.05e-05	0.000109	CbGpPWpGaD
Bosutinib—LYN—Immune System—RIPK2—leprosy	5.04e-05	0.000109	CbGpPWpGaD
Bosutinib—LYN—Immune System—TLR2—leprosy	5.04e-05	0.000109	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—CD4—leprosy	5.03e-05	0.000108	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—CD4—leprosy	5.03e-05	0.000108	CbGpPWpGaD
Bosutinib—SRC—Immune System—PARK2—leprosy	5.02e-05	0.000108	CbGpPWpGaD
Bosutinib—ABL1—Immune System—TLR2—leprosy	5.02e-05	0.000108	CbGpPWpGaD
Bosutinib—ABL1—Immune System—RIPK2—leprosy	5.02e-05	0.000108	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—IL2—leprosy	5.01e-05	0.000108	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—RIPK2—leprosy	4.98e-05	0.000107	CbGpPWpGaD
Bosutinib—FYN—Immune System—RIPK2—leprosy	4.97e-05	0.000107	CbGpPWpGaD
Bosutinib—FYN—Immune System—TLR2—leprosy	4.97e-05	0.000107	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—TLR2—leprosy	4.94e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—RIPK2—leprosy	4.94e-05	0.000106	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD40LG—leprosy	4.92e-05	0.000106	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	4.9e-05	0.000106	CbGpPWpGaD
Bosutinib—TBK1—Immune System—IFNG—leprosy	4.89e-05	0.000105	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD8A—leprosy	4.86e-05	0.000105	CbGpPWpGaD
Bosutinib—CSK—Disease—CD4—leprosy	4.86e-05	0.000105	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—IL2—leprosy	4.86e-05	0.000105	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—CD4—leprosy	4.86e-05	0.000105	CbGpPWpGaD
Bosutinib—CSK—Immune System—IL2—leprosy	4.84e-05	0.000104	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—IFNG—leprosy	4.8e-05	0.000103	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—CD4—leprosy	4.8e-05	0.000103	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—NOD2—leprosy	4.79e-05	0.000103	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—HLA-DRB1—leprosy	4.76e-05	0.000102	CbGpPWpGaD
Bosutinib—TBK1—Immune System—CD4—leprosy	4.72e-05	0.000102	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TNF—leprosy	4.71e-05	0.000101	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—IFNG—leprosy	4.69e-05	0.000101	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—NOD2—leprosy	4.67e-05	0.000101	CbGpPWpGaD
Bosutinib—SRC—Disease—SLC11A1—leprosy	4.64e-05	9.99e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—IL2—leprosy	4.64e-05	9.98e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—CD4—leprosy	4.63e-05	9.98e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD40LG—leprosy	4.63e-05	9.97e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD40LG—leprosy	4.63e-05	9.96e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD8A—leprosy	4.58e-05	9.86e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD8A—leprosy	4.57e-05	9.85e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—NOD2—leprosy	4.57e-05	9.85e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—IFNG—leprosy	4.56e-05	9.82e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NOD2—leprosy	4.55e-05	9.81e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—CD4—leprosy	4.53e-05	9.75e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—CD4—leprosy	4.52e-05	9.73e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—NOD2—leprosy	4.5e-05	9.7e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NOD2—leprosy	4.48e-05	9.65e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—IL2—leprosy	4.44e-05	9.57e-05	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.44e-05	9.56e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—RIPK2—leprosy	4.44e-05	9.55e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—CD4—leprosy	4.4e-05	9.48e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—RIPK2—leprosy	4.37e-05	9.42e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HLA-DRB1—leprosy	4.37e-05	9.4e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—IFNG—leprosy	4.36e-05	9.38e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—IL2—leprosy	4.34e-05	9.36e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—CD4—leprosy	4.34e-05	9.34e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—RIPK2—leprosy	4.29e-05	9.24e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—TLR2—leprosy	4.29e-05	9.24e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—IL2—leprosy	4.26e-05	9.18e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HLA-DRB1—leprosy	4.23e-05	9.12e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CD4—leprosy	4.21e-05	9.06e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	4.21e-05	9.06e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—IFNG—leprosy	4.18e-05	9.01e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—HLA-DRB1—leprosy	4.18e-05	8.99e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—IL2—leprosy	4.16e-05	8.97e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—RIPK2—leprosy	4.15e-05	8.94e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—RIPK2—leprosy	4.14e-05	8.91e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—TLR2—leprosy	4.14e-05	8.91e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CD4—leprosy	4.07e-05	8.76e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—IL2—leprosy	4.05e-05	8.73e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD40LG—leprosy	4.05e-05	8.72e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD4—leprosy	4.04e-05	8.7e-05	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—IL2—leprosy	4.01e-05	8.63e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD8A—leprosy	4e-05	8.62e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HLA-DRB1—leprosy	3.96e-05	8.53e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD40LG—leprosy	3.95e-05	8.51e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD4—leprosy	3.95e-05	8.5e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IFNG—leprosy	3.94e-05	8.49e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RIPK2—leprosy	3.91e-05	8.41e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD8A—leprosy	3.9e-05	8.41e-05	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TNF—leprosy	3.89e-05	8.38e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NOD2—leprosy	3.89e-05	8.38e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—IL2—leprosy	3.88e-05	8.37e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IFNG—leprosy	3.88e-05	8.36e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—IL2—leprosy	3.87e-05	8.34e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD40LG—leprosy	3.87e-05	8.33e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—IL2—leprosy	3.85e-05	8.3e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD4—leprosy	3.85e-05	8.29e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD40LG—leprosy	3.85e-05	8.29e-05	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TNF—leprosy	3.84e-05	8.26e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—IL2—leprosy	3.84e-05	8.26e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD8A—leprosy	3.82e-05	8.23e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD40LG—leprosy	3.81e-05	8.2e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD8A—leprosy	3.81e-05	8.2e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD4—leprosy	3.81e-05	8.2e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—IL2—leprosy	3.79e-05	8.17e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—IFNG—leprosy	3.79e-05	8.16e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD40LG—leprosy	3.79e-05	8.16e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—IFNG—leprosy	3.78e-05	8.14e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD4—leprosy	3.77e-05	8.12e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD8A—leprosy	3.76e-05	8.11e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD4—leprosy	3.75e-05	8.08e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD4—leprosy	3.75e-05	8.08e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—NOD2—leprosy	3.75e-05	8.07e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD8A—leprosy	3.74e-05	8.06e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD4—leprosy	3.73e-05	8.03e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-DRB1—leprosy	3.73e-05	8.03e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-DRB1—leprosy	3.72e-05	8.02e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—IL2—leprosy	3.72e-05	8.01e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD4—leprosy	3.71e-05	7.99e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD4—leprosy	3.7e-05	7.96e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD4—leprosy	3.69e-05	7.95e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD4—leprosy	3.66e-05	7.88e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—RIPK2—leprosy	3.66e-05	7.88e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—TLR2—leprosy	3.66e-05	7.88e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD4—leprosy	3.65e-05	7.86e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—IL2—leprosy	3.64e-05	7.84e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD4—leprosy	3.62e-05	7.8e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD4—leprosy	3.56e-05	7.68e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD4—leprosy	3.51e-05	7.57e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IL2—leprosy	3.5e-05	7.54e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IFNG—leprosy	3.47e-05	7.48e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IL2—leprosy	3.45e-05	7.43e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RIPK2—leprosy	3.41e-05	7.35e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL2—leprosy	3.37e-05	7.25e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL2—leprosy	3.36e-05	7.23e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD4—leprosy	3.35e-05	7.23e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RIPK2—leprosy	3.33e-05	7.18e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—NOD2—leprosy	3.32e-05	7.15e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL2—leprosy	3.3e-05	7.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD40LG—leprosy	3.29e-05	7.08e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RIPK2—leprosy	3.26e-05	7.03e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-DRB1—leprosy	3.26e-05	7.02e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD8A—leprosy	3.25e-05	7e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL2—leprosy	3.24e-05	6.98e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL2—leprosy	3.24e-05	6.98e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RIPK2—leprosy	3.21e-05	6.92e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD4—leprosy	3.21e-05	6.91e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RIPK2—leprosy	3.19e-05	6.88e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-DRB1—leprosy	3.18e-05	6.85e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD40LG—leprosy	3.17e-05	6.83e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—IL2—leprosy	3.16e-05	6.8e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD8A—leprosy	3.13e-05	6.75e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL2—leprosy	3.13e-05	6.74e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-DRB1—leprosy	3.11e-05	6.71e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-DRB1—leprosy	3.1e-05	6.67e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD4—leprosy	3.1e-05	6.67e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IFNG—leprosy	3.09e-05	6.66e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD4—leprosy	3.09e-05	6.66e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL2—leprosy	3.09e-05	6.65e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD4—leprosy	3.08e-05	6.63e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-DRB1—leprosy	3.06e-05	6.6e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SDHD—leprosy	3.06e-05	6.58e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IFNG—leprosy	3.05e-05	6.57e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-DRB1—leprosy	3.05e-05	6.57e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TNF—leprosy	2.99e-05	6.45e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD4—leprosy	2.99e-05	6.43e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD4—leprosy	2.97e-05	6.39e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD4—leprosy	2.94e-05	6.34e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IFNG—leprosy	2.89e-05	6.23e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TNF—leprosy	2.86e-05	6.16e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TNF—leprosy	2.85e-05	6.13e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TNF—leprosy	2.82e-05	6.07e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD40LG—leprosy	2.81e-05	6.04e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TNF—leprosy	2.8e-05	6.03e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—IL2—leprosy	2.8e-05	6.02e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD4—leprosy	2.79e-05	6.02e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD8A—leprosy	2.77e-05	5.98e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RIPK2—leprosy	2.77e-05	5.98e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL2—leprosy	2.75e-05	5.92e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD4—leprosy	2.74e-05	5.89e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IFNG—leprosy	2.72e-05	5.87e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL2—leprosy	2.71e-05	5.84e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RIPK2—leprosy	2.67e-05	5.76e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-DRB1—leprosy	2.65e-05	5.7e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD4—leprosy	2.63e-05	5.66e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD4—leprosy	2.63e-05	5.66e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.63e-05	5.66e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL2—leprosy	2.62e-05	5.64e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL2—leprosy	2.57e-05	5.54e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-DRB1—leprosy	2.55e-05	5.5e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—leprosy	2.43e-05	5.24e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL2—leprosy	2.42e-05	5.21e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IFNG—leprosy	2.38e-05	5.13e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RIPK2—leprosy	2.37e-05	5.1e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IFNG—leprosy	2.32e-05	5e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL2—leprosy	2.31e-05	4.99e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD4—leprosy	2.3e-05	4.95e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IFNG—leprosy	2.27e-05	4.9e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL2—leprosy	2.26e-05	4.88e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IFNG—leprosy	2.26e-05	4.87e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-DRB1—leprosy	2.26e-05	4.87e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD4—leprosy	2.24e-05	4.83e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IFNG—leprosy	2.24e-05	4.82e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL2—leprosy	2.23e-05	4.81e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IFNG—leprosy	2.23e-05	4.8e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD4—leprosy	2.2e-05	4.73e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD4—leprosy	2.19e-05	4.71e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL2—leprosy	2.17e-05	4.66e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD4—leprosy	2.16e-05	4.66e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD4—leprosy	2.15e-05	4.63e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL2—leprosy	2.15e-05	4.63e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD4—leprosy	2.12e-05	4.57e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL2—leprosy	2.11e-05	4.55e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—leprosy	2.08e-05	4.47e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD4—leprosy	2.07e-05	4.46e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL2—leprosy	2.07e-05	4.46e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL2—leprosy	2.07e-05	4.46e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL2—leprosy	2.06e-05	4.44e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL2—leprosy	2.02e-05	4.35e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL2—leprosy	2.01e-05	4.33e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD4—leprosy	2e-05	4.3e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL2—leprosy	2e-05	4.3e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL2—leprosy	1.99e-05	4.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD4—leprosy	1.99e-05	4.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL2—leprosy	1.98e-05	4.26e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFNG—leprosy	1.93e-05	4.17e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SDHD—leprosy	1.88e-05	4.06e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2—leprosy	1.88e-05	4.05e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—leprosy	1.87e-05	4.02e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—leprosy	1.86e-05	4.01e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—leprosy	1.8e-05	3.88e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—leprosy	1.78e-05	3.83e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—leprosy	1.75e-05	3.77e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—leprosy	1.72e-05	3.71e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—leprosy	1.72e-05	3.7e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—leprosy	1.66e-05	3.58e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—leprosy	1.66e-05	3.58e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—leprosy	1.66e-05	3.57e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—leprosy	1.65e-05	3.55e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—leprosy	1.59e-05	3.43e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—leprosy	1.56e-05	3.37e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—leprosy	1.47e-05	3.17e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—leprosy	1.47e-05	3.16e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—leprosy	1.37e-05	2.94e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—leprosy	1.33e-05	2.87e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—leprosy	1.31e-05	2.81e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—leprosy	1.29e-05	2.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—leprosy	1.28e-05	2.76e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—leprosy	1.11e-05	2.39e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—leprosy	1.07e-05	2.31e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—leprosy	9.48e-06	2.04e-05	CbGpPWpGaD
